These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 37558549)
1. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease. Geertsema S; Bourgonje AR; Fagundes RR; Gacesa R; Weersma RK; van Goor H; Mann GE; Dijkstra G; Faber KN Trends Mol Med; 2023 Oct; 29(10):830-842. PubMed ID: 37558549 [TBL] [Abstract][Full Text] [Related]
2. The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases. Piotrowska M; Swierczynski M; Fichna J; Piechota-Polanczyk A Pharmacol Res; 2021 Jan; 163():105243. PubMed ID: 33080322 [TBL] [Abstract][Full Text] [Related]
3. Regulation of Keap1-Nrf2 signaling in health and diseases. Xiao JL; Liu HY; Sun CC; Tang CF Mol Biol Rep; 2024 Jul; 51(1):809. PubMed ID: 39001962 [TBL] [Abstract][Full Text] [Related]
4. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling. Kaur G; Sharma A; Bhatnagar A Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206 [TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases. Kim MJ; Jeon JH Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269986 [TBL] [Abstract][Full Text] [Related]
6. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1). Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166 [TBL] [Abstract][Full Text] [Related]
7. The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging. Yu C; Xiao JH Oxid Med Cell Longev; 2021; 2021():6635460. PubMed ID: 34012501 [TBL] [Abstract][Full Text] [Related]
8. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism. Song MY; Lee DY; Chun KS; Kim EH Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo. Lin X; Meng X; Song Z; Lin J Arch Biochem Biophys; 2020 Dec; 696():108670. PubMed ID: 33186606 [TBL] [Abstract][Full Text] [Related]
10. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review. Singh E; Matada GSP; Abbas N; Dhiwar PS; Ghara A; Das A Inflammopharmacology; 2021 Oct; 29(5):1347-1355. PubMed ID: 34373972 [TBL] [Abstract][Full Text] [Related]
11. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones. de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040 [TBL] [Abstract][Full Text] [Related]
12. Recent progress and applications of small molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative diseases. Wang J; Cao Y; Lu Y; Zhu H; Zhang J; Che J; Zhuang R; Shao J Eur J Med Chem; 2024 Jan; 264():115998. PubMed ID: 38043492 [TBL] [Abstract][Full Text] [Related]
13. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection. Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F J Virol; 2020 May; 94(10):. PubMed ID: 32161178 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis. Sun X; Zuo H; Liu C; Yang Y Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160 [TBL] [Abstract][Full Text] [Related]
15. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Bono S; Feligioni M; Corbo M Mol Neurodegener; 2021 Oct; 16(1):71. PubMed ID: 34663413 [TBL] [Abstract][Full Text] [Related]
16. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway. Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872 [TBL] [Abstract][Full Text] [Related]
17. Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476 [TBL] [Abstract][Full Text] [Related]
18. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease. Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519 [TBL] [Abstract][Full Text] [Related]
19. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update. Lu MC; Ji JA; Jiang ZY; You QD Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495 [TBL] [Abstract][Full Text] [Related]
20. Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells. Guo SP; Chang HC; Lu LS; Liu DZ; Wang TJ Biomed Pharmacother; 2021 Sep; 141():111834. PubMed ID: 34153850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]